the 168th Issue:Drug maker Novartis loses India patent battle-China Intellectual Property

India’s Supreme Court on Monday rejected drug maker Novartis AG’s attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines... More

·Chinese company sues Apple over patent dispute

A Chinese company met Apple Inc in court on Wednesday, accusing the US-based tech giant of intellectual property right infringement regarding software used in its popular Siri software... More

· Trademarks no longer ’famous’

· Intellectual property training

·Patent app for mobile devices

· Patent-collateralized loan

· Intellectual property work group meets

· Wuhan to overhaul IP laws

· SIPO to analyze more sectors

· Qihoo 360 loses suit against Tencent

· Domestic makers of LEDs struggle to climb value chain

· GIs now record 1,441 in China

· Drug patent issue became the focus of the Canada-EU free trade deaIssue 53, By Doris Li, China IP,[Patent]

In September 2012, talks on the free trade agreement between Canada and EU drew near a conclusion. It has been reported that during the final negotiations the issue of drug related IP became the focal point. The key issue was whether or not Canada would agree to abide by the EU standards and extend the term of data exclusivity from eight years to ten years..... More

· Should there be a Crack Down on Genuine Product Importation?Issue 53, By Jessie Chen, China IP,[Trademark]

Last year, some international brands launched rigorous operations to crack down on counterfeits sold both in store and on electronic commerce sites. However, the operations also targeted genuine products sourced from other purchase channels.... More